Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Demerlé C, Gorvel L, Mello M, et al. Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors. J Immunother Cancer 2023;11:e006348. doi: 10.1136/jitc-2022-006348
In the original publication, Daniel Olive was not listed as a co-corresponding author. This has now been rectified.